Biopharmaceuticals VS BRANDS 6/19/25 Biopharmaceuticals VS BRANDS 6/19/25 PolyActiva Appoints Jerry St. Peter as CEO and Secures $25M Series C Funding for U.S. Expansion and Clinical Development Read More
Biopharmaceuticals VS BRANDS 6/19/25 Biopharmaceuticals VS BRANDS 6/19/25 PolyActiva Appoints Jerry St. Peter as CEO and Secures $25M Series C Funding for U.S. Expansion and Clinical Development Read More